相关实验视频

Updated: May 9, 2025

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

Published on: August 23, 2019

在甲状腺癌中CD47表达的纳米体PET成像

Weiqi Wang¹, Jinyuan Zhang¹, Zhan Li¹

¹Department of Nuclear Medicine, Peking University Shenzhen Hospital, Shenzhen 518036, Guangdong, China.

Molecular pharmaceutics

|May 6, 2025

概括

这项研究表明,一种针对CD47,[68Ga]Ga-NOTA-ABDC2的新型PET成像追踪器,可以通过可视化CD47阳性瘤来有效诊断甲状腺癌. 这种追踪剂提供了改善的瘤吸收和特异性,用于潜在的临床应用.

科学领域:

内分泌学在内分泌学.
在瘤学瘤学.
核医学就是核医学.

背景情况:

甲状腺癌是最常见的内分泌恶性瘤.
增加CD47表达与甲状腺癌进展相关.
CD47是甲状腺癌的潜在诊断和治疗点.

研究的目的:

在甲状腺癌模型中使用免疫-质子辐射断层扫描 (immunoPET) 评估CD47向纳米体的诊断潜力.
开发和评估用于可视化甲状腺瘤中CD47表达的新型放射追踪剂.

主要方法:

免疫组织化学 (IHC) 评估了患者组织和甲状腺癌异位移植中的CD47表达 (OCUT-2C,TPC-1,BCPAP).
两个针对CD47的纳米体,C2和ABDC2,被标记为68Ga.
在甲状腺癌模型中使用[68Ga]Ga-NOTA-C2和[68Ga]Ga-NOTA-ABDC2进行了免疫PET成像.

主要成果:

在34.69%的甲状腺癌组织以及OCUT-2C,TPC-1和BCPAP异位移植中,IHC证实了高CD47表达.
[68Ga]Ga-NOTA-ABDC2和[68Ga]Ga-NOTA-C2通过微PET可视化了OCUT-2C瘤.
[68Ga]Ga-NOTA-ABDC2在TPC-1和BCPAP模型中与[68Ga]Ga-NOTA-C2.2.相比,显示出明显更高的瘤吸收率和特定吸收率.

结论:

[68Ga]Ga-NOTA-ABDC2是一种有效的PET成像放射追踪器,通过向CD47.7来诊断甲状腺癌.
这种标志物显示了特定和增强的瘤吸收,有助于识别CD47表达.
临床应用可能有助于患者选择CD47向疗法和响应监测.

关键词:

CD47 CD47 CD47 CD47 CD47 CD47 CD47 CD47 CD47 CD47 CD47 CD47 免疫性PET是一种PET.纳米体是一个纳米体.甲状腺癌是一种癌症.

更多相关视频

In Vivo Immunofluorescence Localization for Assessment of Therapeutic and Diagnostic Antibody Biodistribution in Cancer Research

In Vivo Immunofluorescence Localization for Assessment of Therapeutic and Diagnostic Antibody Biodistribution in Cancer Research

Published on: September 16, 2019

An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma

An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma

Published on: April 17, 2013

相关概念视频

Imaging Studies II: Positron Emission Tomography and Scintigraphy

Imaging Studies II: Positron Emission Tomography and Scintigraphy

Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET

Positron Emission Tomography

Positron Emission Tomography

Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...